Has Brenda Simpson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,430 in general payments to Brenda Simpson, MD across 125 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brenda Simpson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brenda Simpson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brenda Simpson, MD

Dermatology · El Paso, TXNPI 1750676250

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Pfizer at 43.2% of the total. Reporting peaked in 2024 at $13,350 and has fallen 72.1% since, to $3,719 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,430in general payments, 2019–2025

Across 125 payments — averaging $275.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$15K
Incyte Corporation$9K
Sanofi$8K
Strata Skin Sciences, Inc.$546
AstraZeneca$451
AbbVie$412
plus $1K from 16 others

$77,495in research payments, 2019–2025

Across 16 payments — averaging $4843.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$42K
Pfizer$29K
Incyte Corporation$6K

What the payments were for

Consulting fees$11,50233%
Speaking & faculty fees$17,86552%
Travel & lodging$1,4234%
Food & beverage$3,34610%
Education$2951%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	22	$14,875
Incyte Corporation	18	$9,306
Sanofi	21	$7,572
Strata Skin Sciences, Inc.	15	$546
AstraZeneca	5	$451
AbbVie	12	$412
E.r. Squibb & Sons, L.L.C.	3	$242
Johnson & Johnson	4	$231
UCB, Inc.	6	$144
Novartis	2	$122
Lilly USA, LLC	1	$98
Sun Pharmaceutical Industries Inc.	1	$97
Dermavant Sciences, Inc.	1	$79
Krystal Biotech Inc	3	$59
Galderma Laboratories, L.p.	1	$47
Springworks Therapeutics, Inc.	2	$31
LEO Pharma Inc.	1	$25
Arcutis Biotherapeutics, Inc.	1	$25
Amgen	1	$19
Journey Medical Corporation	1	$18
Organon	3	$17
Janssen Scientific Affairs, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,430 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$123,193

Medicare patients

338

Services billed

1,890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	106	$4,303
Triamcinolone Acetonide	67	$1,043
Doxycycline Monohydrate	20	$649
Ketoconazole	40	$544
Mupirocin	42	$388
Clindamycin Phosphate	12	$313
Cephalexin	40	$239
Nystatin	12	$135
Hydroxyzine Hcl	14	$128
Minoxidil	12	$91
Hydrocortisone	14	$78
Prednisone	12	$31

Paid to pharmacies, not to this prescriber.

Other dermatology in El Paso

Edward LainAustin$2.5M
William CragunSan Antonio$2.2M
Alpesh DesaiHouston$1.6M
Craig TellerBellaire$1.3M
Jennifer CatherDallas$1.3M
Emily BeckerSan Antonio$1.2M
Ross RaduskyDallas$1.2M
Joseph MerolaDallas$1.2M
Daniel CarrascoAustin$1.1M
Dale SchaeferAustin$1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →